KCR provides functional outsourcing solutions to medical device, pharmaceutical, biotech companies.

Under the acquisition, KCR will be combined with inVentiv’s existing functional service provider (FSP) and staffing businesses within PharmaNet/i3 and clinical segment.

The business will deliver clinical staffing and resourcing solutions, ranging from recruitment of clinical development staff in all therapeutic areas to strategic FSP partnerships across multiple clinical trials and geographies.

inVentiv Health CEO Paul Meister said further enhancing the company’s clinical segment capabilities with KCR will allow it to deliver solutions that add value, speed and quality to the drug development process.